Navigation Links
King Pharmaceuticals To Acquire Alpharma for Approximately $1.6 Billion
Date:11/24/2008

ly depend on future events are forward-looking, and the words "anticipate," "believe," "expect," "estimate," "plan," and similar expressions are generally intended to identify forward-looking statements. Such statements are based on management's current expectations, but actual results may differ materially due to various factors such as King's ability to complete the tender offer as expected; King's ability to achieve the synergies and value creation contemplated by the proposed transaction; King's ability to promptly and effectively integrate the businesses of Alpharma Inc. ("Alpharma") and King and any necessary actions to obtain required regulatory approvals; the potential of King's branded pharmaceutical products; expectations regarding the enforceability and effectiveness of product-related patents; expected trends and projections with respect to particular products, reportable segment and income and expense line items; the adequacy of King's liquidity and capital resources; anticipated capital expenditures; the acceptance, priority review or approval of certain New Drug Applications; the development, approval and successful commercialization of certain products; the successful execution of growth and restructuring strategies, including King's accelerated strategic shift; anticipated developments and expansions of King's business; plans for the manufacture of some of King's products; the potential costs, outcomes and timing of research, clinical trials and other development activities involving pharmaceutical products; the development of product line extensions; the expected timing of the initial marketing of certain products; products developed, acquired or in-licensed that may be commercialized; King's intent, beliefs or current expectations, primarily with respect to future operating performance; expectations regarding sales growth, gross margins, manufacturing productivity, capital expenditures and effective tax rates; expectations regarding the outcome of
'/>"/>
SOURCE King Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9

Related medicine news :

1. Transdel Pharmaceuticals Appoints Mr. Lynn Swann, Pro-Football Hall of Famer, ABC Sports Broadcaster, and Former Chairman of the Presidents Council on Physical Fitness and Sports, to Board of Directors
2. Data Published in Nature Medicine Highlights Ability of Peregrine Pharmaceuticals Bavituximab to Cure Lethal Virus Infections
3. Alseres Pharmaceuticals, Inc. Announces $1 Million Financing
4. Keryx Biopharmaceuticals Receives Nasdaq Notification
5. Purdue Pharma L.P. Announces a Global Strategic Alliance With Infinity Pharmaceuticals to Advance Discovery and Development Programs in Oncology and Neuropathic Pain
6. FDA Accepts Vanda Pharmaceuticals Iloperidone Resubmission and Sets New Action Date
7. Amylin Pharmaceuticals to Present at Lazard Capital Markets Healthcare Conference
8. MiddleBrook Pharmaceuticals Reports Third Quarter 2008 Financial Results
9. MAP Pharmaceuticals Reports Third Quarter of 2008 Financial Results
10. Ferring Pharmaceuticals Promotes William Garbarini to Vice President of New Orthopaedics and Urology Business Unit
11. Alexza Pharmaceuticals Announces Upcoming Conference Participation and Webcasts
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/27/2015)... In today's healthcare landscape, where costs are growing ... for doctors and hospitals to keep up with the ... HealthTronics, Inc. is offering a solution to ... clinically sophisticated applications. The company has now broadened its ... Ventures, Inc ., a mobile laser technology company based ...
(Date:5/27/2015)... Dr. Omar Ibrahimi, Dermatologist and Director of the ... selected as part of a controlled launch to be ... physician in Connecticut) to offer the new FDA-cleared ... submental fat (double chin). The procedure is entirely non-invasive, ... minimal risks. Dr. Ibrahimi is an invited faculty trainer ...
(Date:5/27/2015)... NOVAtime Technology, Inc. ( http://www.novatime.com ), a ... organizations, announced today that SanMar Corporation successfully implemented ... attendance and point tracking processes for over 3,000 ... , Family-owned since 1971, Seattle-based SanMar Corporation ... label, and mill brands. SanMar supplies apparel and ...
(Date:5/27/2015)... 27, 2015 In support of a ... issue of the Journal of American Geriatrics Society about ... obesity, Bedford Commons OB-GYN P.A . is reiterating ... sweetener-flavored beverages. , To examine the relationship between ... San Antonio Longitudinal Study of Aging (SALSA) tracked the ...
(Date:5/27/2015)... Rock, AR (PRWEB) May 27, 2015 ... Medix today announce a partnership to provide CMSA's ... Medix community. This collaboration seeks to strengthen the ... measurement through CMSA’s CKP program. The mutually beneficial ... on identifying individual skills of talent in the ...
Breaking Medicine News(10 mins):Health News:HealthTronics Invests in Additional Mobile Medical Technologies As Cost Efficient Solution for Hospitals, Doctors 2Health News:HealthTronics Invests in Additional Mobile Medical Technologies As Cost Efficient Solution for Hospitals, Doctors 3Health News:Connecticut Skin Institute First in Connecticut to Offer New Surgery-Free “Double Chin” Fat Reduction Treatment 2Health News:Connecticut Skin Institute First in Connecticut to Offer New Surgery-Free “Double Chin” Fat Reduction Treatment 3Health News:SanMar Corporation Successfully Implemented NOVAtime Workforce Management Solution across 9 locations 2Health News:SanMar Corporation Successfully Implemented NOVAtime Workforce Management Solution across 9 locations 3Health News:Recent Study About the Link Between Diet Sodas and Abdominal Fat Reinforces Bedford Commons OB-GYN's Recommendation to Drink Plenty of Water 2Health News:Case Management Society of America Partners with Medix to Offer Career and Knowledge Pathways 2Health News:Case Management Society of America Partners with Medix to Offer Career and Knowledge Pathways 3
... amino acid glycine has been shown to be anti-inflammatory ... dietary glycine protected both the lung and liver against ... and improved graft survival after liver transplantation. The influence ... was not known. , A research article to be ...
... a choice of treatment for advanced HCC. CT perfusion ... changes due to TACE therapy for locally advanced HCC. ... this technique in evaluating the efficacy of TACE based ... article published on October 7, 2008 in the ...
... to sign up online at http://www.diabetesatlanta.org , ATLANTA, ... than 600,000 Georgians, could be present in more than,300,000 more, ... disease?, No. The answer is diabetes., And, new ... the U.S. has,nearly doubled in the past 10 years - ...
... for organ donation - where people have to opt out of ... to tackle a growing waiting list for transplant. , That is ... and the illegal trade of body parts, who has recently joined ... are more than 7,500 patients in the UK currently on the ...
... S.C., Oct. 31 InStil Health,Insurance Co., a ... D,prescription drug policies in South Carolina and Georgia, ... been appointed president and,chief operating officer of the ... experience in the health insurance industry,and extensive knowledge ...
... 31 The latest advances in,autism research, treatment ... Conference in Fort Lauderdale. The comprehensive four-day,conference, hosted ... CARE,Clinics, is scheduled for November 13 through 16 ... in Weston, Florida., The conference will feature ...
Cached Medicine News:Health News:As Diabetes Reaches Epidemic Levels in Georgia and U.S., Thousands Drawn to Diabetes University in Atlanta Nov. 8 2Health News:'Opt out' system could solve donor organ shortage, says researcher 2Health News:Jim Hart Named President, COO of InStil Health Insurance Co. 2Health News:National Autism Conference to be Held in Weston, FL November 13-16 2
(Date:5/27/2015)... The Bio-Process Systems Alliance (BPSA) ... Single-Use Summit (ISUS 2015) will be held July ... with a primary focus on the promises and hurdles ... technical topics to business and regulatory presentations, ISUS 2015 ... of the single-use industry as the "go-to" platform in ...
(Date:5/27/2015)... Manitoba , May 27, 2015 ... customers, the Canadian International Pharmacy Association (CIPA) ... medications online from licensed Canadian pharmacies. Approximately 64% of ... maintenance medications from a non-U.S. pharmacy due to ... are not covered under their insurance plan.   ...
(Date:5/27/2015)... May 27, 2015  CytRx Corporation (NASDAQ: CYTR ... oncology, today announced an upcoming poster presentation regarding its ... of Clinical Oncology (ASCO) Annual Meeting, which is being ... Chicago . "I am impressed ... in patients who have undergone treatment with aldoxorubicin across ...
Breaking Medicine Technology:BPSA's 5th Annual Summit to Provide '2020 Vision' for Single-Use Technologies 2BPSA's 5th Annual Summit to Provide '2020 Vision' for Single-Use Technologies 3Canadian International Pharmacy Association (CIPA) Survey of Americans Finds 64% Purchase Medications from Canada Due to Affordability 2Canadian International Pharmacy Association (CIPA) Survey of Americans Finds 64% Purchase Medications from Canada Due to Affordability 3CytRx to Present Aldoxorubicin Clinical Data at the 2015 ASCO Annual Meeting 2CytRx to Present Aldoxorubicin Clinical Data at the 2015 ASCO Annual Meeting 3CytRx to Present Aldoxorubicin Clinical Data at the 2015 ASCO Annual Meeting 4CytRx to Present Aldoxorubicin Clinical Data at the 2015 ASCO Annual Meeting 5
Comfor™ Cast Boot - Rocker Sole - Closed Toe...
The Multi-Purpose Medical-Surgical Shoe...
... assay for the qualitative and ... to Gliadin in human serum. ... be used as an aid ... disorders, mainly Coeliac Disease. This ...
... use as a non-reactive quality assurance reagent in ... gondii (TOXO IgG and TOXO IgM), IgG and ... rubella IgM), IgG and IgM antibodies to cytomegalovirus ... antibodies to herpes simplex virus types 1 and ...
Medicine Products: